Liver Cancer Can Be Treated with Novel Treatments

BTG - TheraSphere™

TELLY AWARD WINNER

Liver cancer is diagnosed every year in 1 out of 35,000 people in the US and is slowly rising.  Liver cancer occurs in men more than women but both are at risk. Join Dr. Maureen Kohi, Assistant Professor at University of California, San Francisco, as she shares information regarding novel treatments for liver cancer.


The Balancing Act


Novel Liver Cancer Therapies

There are novel treatments available to treat primary liver cancer ...a cancer who's numbers are rising.

Did you know that each year 1 out of every 35,000 Americans is diagnosed with liver cancer?

And those numbers are slowly rising. Even though both men and women are at risk, liver cancer occurs in men more than in women. Those with the following risk factors may be at higher risk for getting liver cancer:

o Liver Cirrhosis from Alcohol Abuse
o Hepatitis B Infections
o Hepatitis C Infections
o Obesity

There are novel treatments available to treat primary liver cancer, called liver-directed therapies (using small medical devices to kill tumors). The use of these medical devices can lead to a curative treatment like surgery.
Although it’s not for everyone, many people do not know that liver-directed therapy is an option to treat primary liver cancer. If you’re the right candidate, it can be better tolerated than traditional cancer therapy. Speak to a physician about the options.

BTG is a leader in liver directed therapies – a specialized area in medicine called Interventional Oncology. BTG makes two novel therapies, TheraSphere® and LC Bead®, which are available today to treat liver cancer.

Dr. Maureen Kohi, an Assistant Professor of Clinical, at the University of California, San Francisco, will be on the show to share information, answer questions and share the latest treatment options on January 8, 2015 at 7:30am (ET/PT) on The Balancing Act airing on Lifetime Television.

“BTG is proud to sponsor education on liver cancer treatment options. We want to help doctors see more, reach further and treat smarter. Today we can pinpoint liver cancer and deliver ingenious treatments where they are needed most. We are dedicated to finding elegant new ways to treat liver cancer,” said Ken Pugh, Vice President of US Marketing for the Interventional Oncology Division at BTG.

http://www.btg-im.com or http://www.therasphere.com
TheraSphere® is a trademark of Theragenics Corporation used under license by Biocompatibles UK Ltd.
LC Bead® and LC BeadM1™ are trademarks and/or registered trademarks of Biocompatibles UK Ltd, a BTG International group company. ‘See more, reach further, treat smarter’, ‘Imagine where we can go’, BTG and the BTG roundel logo are trademarks of BTG International Ltd. BTG and the BTG roundel logo are registered trademarks in US, EU and certain other territories.

© 2014 BTG International Ltd. All rights reserved.


The Balancing Act® airing on Lifetime® Talks Novel Therapies for Liver Cancer

FOR IMMEDIATE RELEASE

Media Contact:
O2 Media, Inc.
pamela@o2mediainc.com
(954) 691-1102

The Balancing Act® airing on Lifetime® Lends Expertise on Lending, Novel Therapies for Liver Cancer

Third Federal Savings & Loan, BTG International Take Center Stage on June 9th Show

(POMPANO BEACH, Fla. – PR LOG – June 6 2014) Award-winning morning show The Balancing Act® airing on the Lifetime® Channel welcomes Third Federal S&L and BTG International, Ltd to the show. Make sure to tune in on Monday, June 9th at 7:00 a.m. (ET/PT) as The Balancing Act hosts help jump start the day with animated conversations and trusted information to empower a woman’s life. This show will re-air on June 16, 2014.

Don’t miss these featured segments taking center stage on The Balancing Act:

o Making Smarter Decisions-Helping Families with Responsible Borrowing – Third Federal Savings & Loan
Join Chairman and CEO Marc Stefanski of Third Federal Savings & Loan as he explains how old- fashioned business values are creating new lending opportunities for consumers seeking home mortgages and customized refinancing solutions.
In this “My Money” series, “We have an opportunity to reach an important segment of our target audience – women around the US. We want to help them to save money and make smart financial decisions when it comes to their family’s finances – their mortgage being the biggest piece of their budget,” said Third Federal Chairman and CEO Marc A. Stefanski. http://www.thirdfederal.com

o Primary Liver Cancer Can Be Treated with Novel Therapy — with BTG International
Primary Liver cancer is diagnosed every year in 1 out of 35,000 people in the US and is slowly rising. Liver cancer occurs in men more than women but both are at risk. Join Dr. Maureen Kohi, Assistant Professor at University of California, San Francisco, as she shares information regarding risk factors, symptoms and novel outpatient treatments for primary liver cancer. http://www.btg-im.com

About The Balancing Act® on Lifetime® Television
Now in its 6th year, The Balancing Act continues to empower women in all aspects of their lives. The mission at The Balancing Act is simple – the show strives to help today’s modern woman balance it all by bringing them exceptional solutions to everyday problems. Entertaining, educational and trusted by women, viewers can tune in to America’s premier morning show The Balancing Act on weekday mornings at 7:00 am (ET/PT) airing on Lifetime television. For additional information or to view a segment visit: http://www.thebalancingact.com

For more information regarding O2 Media Inc. Branded Entertainment, Product Placement and TV Brand Integration go to: http://o2mediainc.com/Pages/187/Branded-Entertainment

Join the Conversation!
Like us on Facebook at: https://www.facebook.com/TheBalancingActFans
Follow us on Twitter at: http://twitter.com/#!/balancingacttv
Watch us on YouTube at: http://www.youtube.com/thebalancingact